Qingbin Zhao

277 Yanta West Road
Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 02, 2026

Mitochondria-membrane contact duration: a spatial checkpoint for oxidative cell death.

Mitochondria-membrane contact duration: a spatial checkpoint for oxidative cell death.

Journal: Apoptosis : an international journal on programmed cell death

Published: March 26, 2026

CYP2D6 polymorphism rs1065852 significantly increases the risk of type 2 diabetes.

CYP2D6 polymorphism rs1065852 significantly increases the risk of type 2 diabetes.

Journal: Annals of medicine

Published: March 03, 2025

Fc-Elabela mitigates heart failure without liver and renal toxicity in mice.

Fc-Elabela mitigates heart failure without liver and renal toxicity in mice.

Journal: Frontiers in pharmacology

Published: January 05, 2025

Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: A systematic study of the global burden of disease in 2019.

Analysis of the global burden of CKD-T2DM in young and middle-aged adults in 204 countries and territories from 2000 to 2019: A systematic study of the global burden of disease in 2019.

Journal: Diabetes research and clinical practice

Published: May 22, 2024

Establishment of precise prevention strategies for the occurrence and progression of coronary atherosclerotic heart disease using machine learning.

Establishment of precise prevention strategies for the occurrence and progression of coronary atherosclerotic heart disease using machine learning.

Journal: Heliyon

Published: March 24, 2024

Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease.

Establishment of a potent weighted risk model for determining the progression of diabetic kidney disease.

Journal: Journal of translational medicine

Published: April 12, 2023

FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway.

FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway.

Journal: Cell death discovery

Published: August 20, 2021

PAM variants were associated with type 2 diabetes mellitus risk in the Chinese population.

PAM variants were associated with type 2 diabetes mellitus risk in the Chinese population.

Journal: Functional & integrative genomics

Published: June 21, 2021

A potent weighted risk model for evaluating the occurrence and severity of diabetic foot ulcers.

A potent weighted risk model for evaluating the occurrence and severity of diabetic foot ulcers.

Journal: Diabetology & metabolic syndrome

Published: April 26, 2021

An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study.

An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study.

Journal: Lipids in health and disease

Published: August 31, 2020

A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China.

A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China.

Journal: Acta diabetologica

Published: October 27, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026